CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2014—Biofortuna announced the expansion of its freeze-dried production service. Biofortuna invested in a new, state-of-the-art freeze-drier and additional climate-control units to meet the increased demands of companies that are outsourcing their freeze-dried production of diagnostic kits. The additional freeze-drier and infrastructure almost doubles the company’s production capacity.
Read More »